{"gene":"NOBOX","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2006,"finding":"NOBOX binds specific DNA sequences (TAATTG, TAGTTG, TAATTA) identified as NOBOX binding elements (NBEs) using cyclic amplification of sequence target (CAST) assay and mutation analyses, and directly activates transcription of Pou5f1 and Gdf9 by binding NBEs in their promoters, confirmed by chromatin immunoprecipitation and luciferase reporter assays.","method":"CAST assay, EMSA, chromatin immunoprecipitation (ChIP), luciferase reporter assay, mutational analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (CAST, mutagenesis, ChIP, reporter assay) in a single rigorous study establishing DNA-binding specificity and direct transcriptional targets","pmids":["16997917"],"is_preprint":false},{"year":2007,"finding":"The NOBOX homeodomain missense mutation p.Arg355His disrupts NOBOX binding to the NOBOX DNA-binding element (NBE) and exerts a dominant negative effect on wild-type NOBOX DNA binding, as demonstrated by electrophoretic mobility shift assay (EMSA).","method":"EMSA, Sanger sequencing, mutagenesis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro binding assay with mutagenesis, single lab but rigorous mechanistic characterization","pmids":["17701902"],"is_preprint":false},{"year":2007,"finding":"Nobox deficiency in mice leads to downregulation of oocyte-specific genes (including Pou5f1/Oct4, Sall4, Astl, Jag1, Oosp1, Fetub, Rspo2) and upregulation of the male-determining gene Dmrt1, with protein-binding microarray identifying NBE motifs in the promoters of downregulated genes, indicating Nobox functions as an activator of oocyte-specific gene expression and suppressor of male-determining gene expression.","method":"Microarray (Affymetrix), protein-binding microarray, Nobox knockout mouse model","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal genome-wide methods in KO model, single lab","pmids":["17494914"],"is_preprint":false},{"year":2011,"finding":"Five NOBOX missense mutations (p.G91W, p.R117W, p.S342T, p.V350L, and p.R303X nonsense) reduce the ability of NOBOX protein to bind to and transactivate the GDF9 promoter in transfected cells, consistent with haploinsufficiency as the mechanism underlying POI.","method":"Luciferase reporter assay, transfection, functional transactivation assay","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional assay with multiple alleles tested, single lab","pmids":["21837770"],"is_preprint":false},{"year":2011,"finding":"Loss of Nobox in mice causes defects in germ cell cyst breakdown and failure of somatic cell invasion, resulting in formation of syncytial follicles instead of primordial follicles, with abnormal adherens junctions between unseparated oocytes indicating faulty somatic-germ cell communication.","method":"Electron microscopy (ultrastructural analysis), Nobox knockout mouse model","journal":"Journal of assisted reproduction and genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ultrastructural analysis in KO model with defined cellular phenotype, single lab","pmids":["21369782"],"is_preprint":false},{"year":2010,"finding":"NOBOX directly binds an NBE (core sequence TAATTA) in the Pad6 (peptidylarginine deiminase 6) promoter and activates Pad6 transcription, establishing Pad6 as a direct transcriptional target of NOBOX in oocytes.","method":"EMSA, luciferase reporter assay, Nobox knockout mouse ovary expression analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — direct binding confirmed by EMSA and functional reporter assay in KO model context, single lab","pmids":["20659469"],"is_preprint":false},{"year":2010,"finding":"NOBOX is an essential maternal-derived transcription factor in bovine early embryogenesis; siRNA-mediated knockdown of NOBOX in bovine embryos blocked development to the blastocyst stage, downregulated genes involved in transcriptional regulation, signal transduction, and cell cycle, and reduced pluripotency gene expression (POU5F1/OCT4 and NANOG) and inner cell mass cell number.","method":"siRNA knockdown, RT-PCR, immunofluorescence, blastocyst development assay","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined cellular and molecular phenotypes, single lab, bovine model","pmids":["21193554"],"is_preprint":false},{"year":2011,"finding":"miR-196a directly targets the 3' UTR of bovine NOBOX mRNA to repress NOBOX protein expression; a miR-196a binding site was identified by algorithm, validated by luciferase reporter assay (suppressed by miR-196a, rescued by site-directed mutation of MRE), and ectopic miR-196a in bovine embryos reduced NOBOX at both mRNA and protein levels.","method":"Luciferase reporter assay, site-directed mutagenesis, ectopic miRNA expression in embryos, Western blot","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal methods including mutagenesis and in-embryo validation, single lab, bovine model","pmids":["21548929"],"is_preprint":false},{"year":2014,"finding":"NOBOX directly transactivates the KIT-L (KITLG/stem cell factor) promoter, identifying KIT-L as a novel direct transcriptional target of NOBOX, confirmed by luciferase reporter assay with POI-associated NOBOX mutations showing reduced KIT-L transactivation.","method":"Luciferase reporter assay, mutational analysis in patient-derived variants","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assay with multiple disease alleles tested, single lab","pmids":["25514101"],"is_preprint":false},{"year":2015,"finding":"A novel NOBOX isoform identified in human fetal ovary (distinct from the canonical transcript) is capable of upregulating the GDF9 promoter in reporter assays, demonstrating that isoform-specific transcriptional regulation of GDF9 by NOBOX occurs during human oogenesis.","method":"qRT-PCR, luciferase reporter assay, NOBOX isoform cloning from human fetal ovary","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assay with novel isoform, single lab","pmids":["25790371"],"is_preprint":false},{"year":2016,"finding":"A homozygous NOBOX truncating variant (chr7:144098161delC) causes severe loss-of-function: the truncated NOBOX protein fails to transactivate the GDF9 promoter, reduces expression of multiple oocyte-related genes, and loses the ability to induce G2/M cell-cycle arrest; the 1725 bp NOBOX transcript expressed in human fetal ovary was confirmed as the only functional isoform in transcriptional activation assays.","method":"Luciferase reporter assay, qRT-PCR, cell cycle analysis, whole exome sequencing, isoform functional comparison","journal":"Human reproduction (Oxford, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays characterizing loss-of-function mechanism, single lab","pmids":["27836978"],"is_preprint":false},{"year":2016,"finding":"Multiple NOBOX variants associated with POI (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449*, p.D452N) exhibit variable functional defects including impaired transcriptional activity, autophagosomal protein degradation, defective nuclear localization, and protein instability; several variants retain the ability to interact with FOXL2 and form intracellular aggregates.","method":"Immunolocalization, Western blot, transcriptional assays, co-localization in HEK293T and CHO cells","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional assays across multiple alleles, single lab","pmids":["27798098"],"is_preprint":false},{"year":2017,"finding":"RSPO2 is a direct transcriptional target of NOBOX: the RSPO2 promoter contains a NOBOX binding element (NBE), and NOBOX activates RSPO2 promoter-driven transcription in reporter assays.","method":"Promoter cloning, luciferase reporter assay, NBE identification","journal":"Journal of ovarian research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single reporter assay, single lab, no ChIP or binding confirmation","pmids":["28743298"],"is_preprint":false},{"year":2019,"finding":"In Xenopus, a Nobox-binding element (NBE) in the proximal promoter of the hb4 gene is essential for its transcriptional activation specifically in oocytes, and Nobox expressed in the ovary drives hb4 transcription through this NBE, demonstrated by deletion analysis and luciferase reporter assays in transgenic frogs.","method":"Transgenic reporter analysis, promoter deletion constructs, luciferase reporter assay","journal":"Zygote (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic validation plus reporter assays, single lab, Xenopus model consistent with mammalian NOBOX function","pmids":["31250783"],"is_preprint":false},{"year":2022,"finding":"Loss of nobox in zebrafish (CRISPR/Cas9 knockout) prevents follicles from developing beyond the primary growth (perinucleolar) stage, resulting in all-male phenotype; follicle assembly from cystic oocytes occurs but follicles fail to progress to functional ovaries, indicating Nobox is required for follicle development after initial assembly.","method":"CRISPR/Cas9 knockout, histological analysis, zebrafish model","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined loss-of-function phenotype with specific developmental stage arrest, single lab, zebrafish ortholog","pmids":["35157068"],"is_preprint":false},{"year":2023,"finding":"In zebrafish nobox-/-;dmrt1-/- double mutants, follicles form and progress to previtellogenic (PV) stage but fail to enter vitellogenic growth due to a deficiency in estrogen signaling, evidenced by reduced ovarian aromatase (cyp19a1a) expression, decreased serum estradiol, regressed female secondary sex characteristics, and rescue of vitellogenic growth by exogenous E2 treatment; Nobox may regulate cyp19a1a via control of Gdf9 and/or Bmp15.","method":"Genetic epistasis (nobox-/-;dmrt1-/- double mutant), qRT-PCR, serum hormone measurement, E2 rescue experiment, zebrafish model","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with defined rescue experiment placing Nobox upstream of estrogen signaling in folliculogenesis, single lab","pmids":["37990081"],"is_preprint":false},{"year":2023,"finding":"Mouse NOBOX is sumoylated by SUMO2/3 at a non-consensus site (K97); loss of NOBOX sumoylation at K97 (K97R mutation) increases transcriptional activity on the Gdf9 promoter but has no effect on the Pou5f1 promoter; K97R/K125R double mutants show altered higher molecular weight SUMO modifications, suggesting cooperation between these lysines in regulating NOBOX transcriptional output.","method":"Site-directed mutagenesis, sumoylation assay, luciferase reporter assay, Western blot","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sumoylation site identified by mutagenesis with functional consequences on promoter activity, single lab","pmids":["36607631"],"is_preprint":false},{"year":2012,"finding":"A distal NOBOX binding element (NBE) at -1.8 kb upstream of the TSS in the buffalo GDF9 promoter enhances GDF9 promoter activity in buffalo oocytes; site-directed mutation of the core NBE nucleotides abolished this enhancement, confirming the NBE is required for NOBOX-mediated transcriptional activation of GDF9.","method":"Promoter deletion constructs, luciferase reporter assay, GFP reporter, site-directed mutagenesis, oocyte transfection","journal":"Animal reproduction science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of binding element in native oocyte context with two orthogonal reporters, single lab","pmids":["23078866"],"is_preprint":false}],"current_model":"NOBOX is an oocyte-specific homeodomain transcription factor that binds NOBOX binding elements (NBEs; core sequences TAATTG, TAGTTG, TAATTA) in target gene promoters to directly activate transcription of oocyte-specific genes including Gdf9, Pou5f1/Oct4, Pad6, KIT-L, and Rspo2; its transcriptional activity is regulated post-translationally by SUMO2/3 modification at K97, and disease-causing mutations disrupt DNA binding, nuclear localization, protein stability, or transactivation capacity; loss of NOBOX in mice and zebrafish blocks the transition from primordial to growing follicles and impairs downstream estrogen signaling, while NOBOX also functions as an essential maternal transcription factor during early embryogenesis in bovines."},"narrative":{"mechanistic_narrative":"NOBOX is an oocyte-specific homeodomain transcription factor that drives the primordial-to-growing follicle transition by directly activating an oocyte gene expression program [PMID:16997917, PMID:17494914]. It binds defined NOBOX binding elements (NBEs; core sequences TAATTG, TAGTTG, TAATTA) in target promoters and transactivates a set of oocyte-specific and pluripotency genes including Gdf9, Pou5f1/Oct4, Pad6, and KIT-L/KITLG [PMID:16997917, PMID:20659469, PMID:25514101]. Genome-wide loss-of-function in mice establishes NOBOX as both an activator of oocyte-specific genes (Pou5f1, Sall4, Astl, Rspo2 among others) and a suppressor of the male-determining gene Dmrt1 [PMID:17494914]; at the cellular level Nobox loss disrupts germ cell cyst breakdown and somatic cell invasion, producing syncytial rather than primordial follicles [PMID:21369782]. In zebrafish, nobox is required for follicles to progress beyond the primary growth stage, and genetic epistasis places Nobox upstream of estrogen signaling, acting through aromatase (cyp19a1a) and Gdf9/Bmp15 to license vitellogenic growth [PMID:35157068, PMID:37990081]. Beyond its ovarian role, NOBOX functions as an essential maternal transcription factor in bovine early embryogenesis, where its knockdown blocks blastocyst development and reduces pluripotency gene expression [PMID:21193554]. NOBOX transcriptional output is tuned post-translationally by SUMO2/3 modification at K97, loss of which selectively elevates activity on the Gdf9 promoter [PMID:36607631]. Human NOBOX mutations cause primary ovarian insufficiency: missense and truncating variants impair DNA binding, transactivation, nuclear localization, and protein stability, with a homeodomain mutation (p.Arg355His) acting dominant-negatively on wild-type DNA binding [PMID:17701902, PMID:21837770, PMID:27836978, PMID:27798098].","teleology":[{"year":2006,"claim":"Established NOBOX as a sequence-specific DNA-binding transcription factor with defined recognition elements and direct target genes, converting it from a candidate oocyte factor into a defined transcriptional activator.","evidence":"CAST selection, EMSA, ChIP, and luciferase reporters defining NBEs and direct activation of Pou5f1 and Gdf9","pmids":["16997917"],"confidence":"High","gaps":["Full target repertoire not defined","Co-activators/co-repressors at NBEs not identified"]},{"year":2007,"claim":"Showed that a disease homeodomain mutation abolishes NBE binding and acts dominant-negatively, linking NOBOX DNA-binding function directly to human ovarian disease mechanism.","evidence":"EMSA with the p.Arg355His mutant in human POI patients","pmids":["17701902"],"confidence":"High","gaps":["Dominant-negative mechanism not tested in vivo","Effect on transcription of endogenous targets not shown"]},{"year":2007,"claim":"Defined the genome-wide consequences of Nobox loss, establishing it as an activator of oocyte genes and a suppressor of the male-determining gene Dmrt1.","evidence":"Affymetrix microarray and protein-binding microarray in Nobox knockout mouse ovary","pmids":["17494914"],"confidence":"Medium","gaps":["Direct vs indirect targets not fully distinguished","Mechanism of Dmrt1 suppression unresolved"]},{"year":2011,"claim":"Defined the cellular phenotype of Nobox loss as failed cyst breakdown and somatic invasion, connecting transcriptional activity to follicle architecture.","evidence":"Electron microscopy of Nobox knockout mouse ovaries","pmids":["21369782"],"confidence":"Medium","gaps":["Target genes mediating cyst breakdown not identified","Adherens junction link to NOBOX targets unestablished"]},{"year":2010,"claim":"Expanded the direct target set to Pad6 and established NOBOX as a maternal transcription factor required for early embryogenesis beyond the ovary.","evidence":"EMSA and reporter assays for Pad6; siRNA knockdown with blastocyst assays in bovine embryos","pmids":["20659469","21193554"],"confidence":"Medium","gaps":["Maternal vs zygotic contribution not separated","Embryonic targets only partially defined"]},{"year":2011,"claim":"Identified post-transcriptional control of NOBOX by miR-196a and refined haploinsufficiency as the mechanism for POI-associated alleles.","evidence":"Luciferase 3'UTR reporter with MRE mutagenesis and in-embryo miRNA expression; transactivation assays of five POI missense/nonsense alleles on GDF9","pmids":["21548929","21837770"],"confidence":"Medium","gaps":["miR-196a regulation shown in bovine only","Allele-specific quantitative contribution to haploinsufficiency unresolved"]},{"year":2012,"claim":"Mapped a functional distal NBE in the GDF9 promoter, confirming NBE-dependent transactivation in a native oocyte context.","evidence":"Promoter deletion and NBE mutagenesis with dual reporters in buffalo oocytes","pmids":["23078866"],"confidence":"Medium","gaps":["Endogenous occupancy not confirmed by ChIP","Proximal vs distal NBE cooperation not addressed"]},{"year":2014,"claim":"Added KIT-L/KITLG to the direct NOBOX target set and tied POI mutations to reduced KIT-L transactivation, connecting NOBOX to somatic-germ cell signaling ligands.","evidence":"Luciferase reporter assays with patient-derived NOBOX variants","pmids":["25514101"],"confidence":"Medium","gaps":["Direct binding to KIT-L promoter not confirmed by ChIP/EMSA","In vivo relevance not shown"]},{"year":2015,"claim":"Demonstrated isoform-specific transcriptional regulation of GDF9 during human oogenesis, refining which NOBOX transcript carries activity.","evidence":"Isoform cloning from human fetal ovary with GDF9 reporter assays","pmids":["25790371"],"confidence":"Medium","gaps":["Relative abundance/role of isoforms in vivo unclear","Structural basis of isoform activity not defined"]},{"year":2016,"claim":"Characterized the loss-of-function spectrum of human NOBOX variants, revealing multiple convergent defects (transactivation, nuclear localization, stability, autophagic degradation, cell-cycle arrest) and confirming the single functional fetal-ovary isoform.","evidence":"Reporter, qRT-PCR, cell-cycle, immunolocalization, Western blot across multiple POI alleles and a homozygous truncating variant","pmids":["27836978","27798098"],"confidence":"Medium","gaps":["FOXL2 interaction functional consequence not resolved","Aggregate formation mechanism unknown"]},{"year":2017,"claim":"Proposed RSPO2 as an additional direct NOBOX target via an NBE-containing promoter.","evidence":"Promoter cloning and luciferase reporter assay","pmids":["28743298"],"confidence":"Low","gaps":["Single reporter assay with no ChIP or binding confirmation","In vivo dependence not tested"]},{"year":2019,"claim":"Provided in vivo transgenic evidence that an NBE drives oocyte-specific transcription, generalizing NOBOX-NBE regulation to a vertebrate ovarian gene.","evidence":"Transgenic reporter and promoter deletion analysis of hb4 in Xenopus","pmids":["31250783"],"confidence":"Medium","gaps":["Endogenous hb4 regulation not assayed in knockouts","Conservation of mechanism in mammals not directly shown"]},{"year":2022,"claim":"Defined the developmental requirement for nobox after follicle assembly, showing arrest at primary growth stage and an all-male phenotype.","evidence":"CRISPR/Cas9 knockout and histology in zebrafish","pmids":["35157068"],"confidence":"Medium","gaps":["Molecular targets mediating arrest not identified","Sex-reversal mechanism not resolved"]},{"year":2023,"claim":"Placed Nobox upstream of estrogen signaling in folliculogenesis via genetic epistasis, showing failure of vitellogenic growth rescuable by exogenous E2.","evidence":"nobox-/-;dmrt1-/- double mutants with qRT-PCR, serum estradiol, and E2 rescue in zebrafish","pmids":["37990081"],"confidence":"Medium","gaps":["Direct regulation of cyp19a1a vs via Gdf9/Bmp15 not distinguished","Mammalian conservation of this axis untested"]},{"year":2023,"claim":"Identified SUMO2/3 modification at K97 as a post-translational regulator that selectively tunes NOBOX transcriptional output on the Gdf9 promoter.","evidence":"Site-directed mutagenesis (K97R, K125R), sumoylation assay, and luciferase reporters","pmids":["36607631"],"confidence":"Medium","gaps":["SUMO E3 ligase and timing in vivo unknown","Promoter selectivity mechanism for Gdf9 vs Pou5f1 unexplained"]},{"year":null,"claim":"How NOBOX integrates co-factor binding (e.g. FOXL2), SUMO modification, and isoform selection to achieve promoter-specific target selection in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of NOBOX-NBE or NOBOX-cofactor complexes","Direct in vivo occupancy across the full target set not mapped","Mechanism coordinating Dmrt1 suppression with oocyte gene activation unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,5,8,16]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5,8]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[4,14,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,14]}],"complexes":[],"partners":["FOXL2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O60393","full_name":"Homeobox protein NOBOX","aliases":[],"length_aa":691,"mass_kda":73.9,"function":"Transcription factor which may play a role in oogenesis. Binds preferentially to the DNA sequences 5'-TAATTG-3', 5'-TAGTTG-3' and 5'-TAATTA-3'","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O60393/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NOBOX","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":77,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NOBOX","total_profiled":1310},"omim":[{"mim_id":"620360","title":"TETRAPEPTIDE REPEAT HOMEOBOX 2; TPRX2","url":"https://www.omim.org/entry/620360"},{"mim_id":"618700","title":"CYTOPLASMIC POLYADENYLATED HOMEOBOX-LIKE; CPHXL","url":"https://www.omim.org/entry/618700"},{"mim_id":"618698","title":"DOUBLE HOMEOBOX B; DUXB","url":"https://www.omim.org/entry/618698"},{"mim_id":"618014","title":"PREMATURE OVARIAN FAILURE 14; POF14","url":"https://www.omim.org/entry/618014"},{"mim_id":"617265","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 9; KCTD9","url":"https://www.omim.org/entry/617265"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NOBOX"},"hgnc":{"alias_symbol":["OG2","Og2x"],"prev_symbol":[]},"alphafold":{"accession":"O60393","domains":[{"cath_id":"1.10.10.60","chopping":"289-313_343-362","consensus_level":"medium","plddt":82.8147,"start":289,"end":362}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60393","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60393-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60393-F1-predicted_aligned_error_v6.png","plddt_mean":47.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOBOX","jax_strain_url":"https://www.jax.org/strain/search?query=NOBOX"},"sequence":{"accession":"O60393","fasta_url":"https://rest.uniprot.org/uniprotkb/O60393.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60393/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60393"}},"corpus_meta":[{"pmid":"17701902","id":"PMC_17701902","title":"NOBOX homeobox mutation causes premature ovarian failure.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17701902","citation_count":187,"is_preprint":false},{"pmid":"11804785","id":"PMC_11804785","title":"Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11804785","citation_count":131,"is_preprint":false},{"pmid":"17494914","id":"PMC_17494914","title":"Microarray analyses of newborn mouse ovaries lacking Nobox.","date":"2007","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17494914","citation_count":109,"is_preprint":false},{"pmid":"21837770","id":"PMC_21837770","title":"Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21837770","citation_count":77,"is_preprint":false},{"pmid":"16997917","id":"PMC_16997917","title":"Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16997917","citation_count":75,"is_preprint":false},{"pmid":"21369782","id":"PMC_21369782","title":"Premature ovarian failure in nobox-deficient mice is caused by defects in somatic cell invasion and germ cell cyst breakdown.","date":"2011","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21369782","citation_count":63,"is_preprint":false},{"pmid":"21548929","id":"PMC_21548929","title":"MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis.","date":"2011","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21548929","citation_count":61,"is_preprint":false},{"pmid":"16597639","id":"PMC_16597639","title":"cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles.","date":"2006","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16597639","citation_count":55,"is_preprint":false},{"pmid":"27836978","id":"PMC_27836978","title":"A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency.","date":"2016","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27836978","citation_count":50,"is_preprint":false},{"pmid":"18930203","id":"PMC_18930203","title":"Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure.","date":"2008","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/18930203","citation_count":47,"is_preprint":false},{"pmid":"21193554","id":"PMC_21193554","title":"A novel functional role for the oocyte-specific transcription factor newborn ovary homeobox (NOBOX) during early embryonic development in cattle.","date":"2010","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21193554","citation_count":43,"is_preprint":false},{"pmid":"25514101","id":"PMC_25514101","title":"New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25514101","citation_count":43,"is_preprint":false},{"pmid":"25790371","id":"PMC_25790371","title":"GDF9 is transiently expressed in oocytes before follicle formation in the human fetal ovary and is regulated by a novel NOBOX transcript.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25790371","citation_count":39,"is_preprint":false},{"pmid":"19480014","id":"PMC_19480014","title":"Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.","date":"2009","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/19480014","citation_count":36,"is_preprint":false},{"pmid":"15950662","id":"PMC_15950662","title":"Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure.","date":"2005","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/15950662","citation_count":33,"is_preprint":false},{"pmid":"27798098","id":"PMC_27798098","title":"Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiency.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27798098","citation_count":23,"is_preprint":false},{"pmid":"26848058","id":"PMC_26848058","title":"NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26848058","citation_count":22,"is_preprint":false},{"pmid":"23585350","id":"PMC_23585350","title":"The NOBOX protein becomes undetectable in developmentally competent antral and ovulated oocytes.","date":"2013","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23585350","citation_count":18,"is_preprint":false},{"pmid":"22670762","id":"PMC_22670762","title":"Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.","date":"2013","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/22670762","citation_count":18,"is_preprint":false},{"pmid":"29067606","id":"PMC_29067606","title":"A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure.","date":"2017","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/29067606","citation_count":18,"is_preprint":false},{"pmid":"35157068","id":"PMC_35157068","title":"Loss of Nobox prevents ovarian differentiation from juvenile ovaries in zebrafish.","date":"2022","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/35157068","citation_count":17,"is_preprint":false},{"pmid":"20659469","id":"PMC_20659469","title":"The oocyte-specific transcription factor, Nobox, regulates the expression of Pad6, a peptidylarginine deiminase in the oocyte.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20659469","citation_count":16,"is_preprint":false},{"pmid":"37990081","id":"PMC_37990081","title":"Genetic evidence for differential functions of figla and nobox in zebrafish ovarian differentiation and folliculogenesis.","date":"2023","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/37990081","citation_count":13,"is_preprint":false},{"pmid":"11685649","id":"PMC_11685649","title":"Expression of mouse osteocalcin transcripts, OG1 and OG2, is differently regulated in bone tissues and osteoblast cultures.","date":"2001","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11685649","citation_count":13,"is_preprint":false},{"pmid":"23936842","id":"PMC_23936842","title":"High-yield soluble expression and simple purification of the antimicrobial peptide OG2 using the intein system in Escherichia coli.","date":"2013","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/23936842","citation_count":12,"is_preprint":false},{"pmid":"28567625","id":"PMC_28567625","title":"Biodegradation of α-endosulfan via hydrolysis pathway by Stenotrophomonas maltophilia OG2.","date":"2017","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28567625","citation_count":10,"is_preprint":false},{"pmid":"28743298","id":"PMC_28743298","title":"R-spondin2, a novel target of NOBOX: identification of variants in a cohort of women with primary ovarian insufficiency.","date":"2017","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/28743298","citation_count":9,"is_preprint":false},{"pmid":"36607631","id":"PMC_36607631","title":"Sumoylation regulates functional properties of the oocyte transcription factors SOHLH1 and NOBOX.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36607631","citation_count":8,"is_preprint":false},{"pmid":"37921973","id":"PMC_37921973","title":"NOBOX gene variants in premature ovarian insufficiency: ethnicity-dependent insights.","date":"2023","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37921973","citation_count":8,"is_preprint":false},{"pmid":"34480423","id":"PMC_34480423","title":"Compound heterozygous null mutations of NOBOX in sisters with delayed puberty and primary amenorrhea.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34480423","citation_count":8,"is_preprint":false},{"pmid":"35257353","id":"PMC_35257353","title":"Hypo-Hydroxymethylation of Nobox is Associated with Ovarian Dysfunction in Rat Offspring Exposed to Prenatal Hypoxia.","date":"2022","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/35257353","citation_count":5,"is_preprint":false},{"pmid":"40246288","id":"PMC_40246288","title":"Reclassifying NOBOX variants in primary ovarian insufficiency cases with a corrected gene model and a novel quantitative framework.","date":"2025","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/40246288","citation_count":4,"is_preprint":false},{"pmid":"23078866","id":"PMC_23078866","title":"A reporter promoter assay confirmed the role of a distal promoter NOBOX binding element in enhancing expression of GDF9 gene in buffalo oocytes.","date":"2012","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/23078866","citation_count":4,"is_preprint":false},{"pmid":"21777853","id":"PMC_21777853","title":"Establishment of novel embryonic stem (ES) cell lines from OG2/rtTA blastocysts.","date":"2011","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/21777853","citation_count":3,"is_preprint":false},{"pmid":"38523712","id":"PMC_38523712","title":"Association between polymorphisms in NOBOX and litter size traits in Xiangsu pigs.","date":"2024","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/38523712","citation_count":2,"is_preprint":false},{"pmid":"19938448","id":"PMC_19938448","title":"Cloning and characterization of porcine NOBOX gene.","date":"2009","source":"Sheng wu gong cheng xue bao = Chinese journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19938448","citation_count":2,"is_preprint":false},{"pmid":"41903788","id":"PMC_41903788","title":"Deletion of the glucocorticoid receptor in osteoblasts and osteocytes drives trabecular bone loss in Col2.3-Cre and OG2-Cre knockout mice.","date":"2026","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/41903788","citation_count":0,"is_preprint":false},{"pmid":"31250783","id":"PMC_31250783","title":"Specific activation of the hb4 gene in the Xenopus oocyte through a Nobox-binding element located at the proximal promoter sequence.","date":"2019","source":"Zygote (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31250783","citation_count":0,"is_preprint":false},{"pmid":"41324758","id":"PMC_41324758","title":"Primary ovarian insufficiency due to homozygous variants in the homeobox transcription factor NOBOX.","date":"2025","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/41324758","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20592,"output_tokens":4192,"usd":0.062328,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12133,"output_tokens":4224,"usd":0.083132,"stage2_stop_reason":"end_turn"},"total_usd":0.14546,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"NOBOX binds specific DNA sequences (TAATTG, TAGTTG, TAATTA) identified as NOBOX binding elements (NBEs) using cyclic amplification of sequence target (CAST) assay and mutation analyses, and directly activates transcription of Pou5f1 and Gdf9 by binding NBEs in their promoters, confirmed by chromatin immunoprecipitation and luciferase reporter assays.\",\n      \"method\": \"CAST assay, EMSA, chromatin immunoprecipitation (ChIP), luciferase reporter assay, mutational analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (CAST, mutagenesis, ChIP, reporter assay) in a single rigorous study establishing DNA-binding specificity and direct transcriptional targets\",\n      \"pmids\": [\"16997917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The NOBOX homeodomain missense mutation p.Arg355His disrupts NOBOX binding to the NOBOX DNA-binding element (NBE) and exerts a dominant negative effect on wild-type NOBOX DNA binding, as demonstrated by electrophoretic mobility shift assay (EMSA).\",\n      \"method\": \"EMSA, Sanger sequencing, mutagenesis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro binding assay with mutagenesis, single lab but rigorous mechanistic characterization\",\n      \"pmids\": [\"17701902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nobox deficiency in mice leads to downregulation of oocyte-specific genes (including Pou5f1/Oct4, Sall4, Astl, Jag1, Oosp1, Fetub, Rspo2) and upregulation of the male-determining gene Dmrt1, with protein-binding microarray identifying NBE motifs in the promoters of downregulated genes, indicating Nobox functions as an activator of oocyte-specific gene expression and suppressor of male-determining gene expression.\",\n      \"method\": \"Microarray (Affymetrix), protein-binding microarray, Nobox knockout mouse model\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal genome-wide methods in KO model, single lab\",\n      \"pmids\": [\"17494914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Five NOBOX missense mutations (p.G91W, p.R117W, p.S342T, p.V350L, and p.R303X nonsense) reduce the ability of NOBOX protein to bind to and transactivate the GDF9 promoter in transfected cells, consistent with haploinsufficiency as the mechanism underlying POI.\",\n      \"method\": \"Luciferase reporter assay, transfection, functional transactivation assay\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional assay with multiple alleles tested, single lab\",\n      \"pmids\": [\"21837770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of Nobox in mice causes defects in germ cell cyst breakdown and failure of somatic cell invasion, resulting in formation of syncytial follicles instead of primordial follicles, with abnormal adherens junctions between unseparated oocytes indicating faulty somatic-germ cell communication.\",\n      \"method\": \"Electron microscopy (ultrastructural analysis), Nobox knockout mouse model\",\n      \"journal\": \"Journal of assisted reproduction and genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ultrastructural analysis in KO model with defined cellular phenotype, single lab\",\n      \"pmids\": [\"21369782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NOBOX directly binds an NBE (core sequence TAATTA) in the Pad6 (peptidylarginine deiminase 6) promoter and activates Pad6 transcription, establishing Pad6 as a direct transcriptional target of NOBOX in oocytes.\",\n      \"method\": \"EMSA, luciferase reporter assay, Nobox knockout mouse ovary expression analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct binding confirmed by EMSA and functional reporter assay in KO model context, single lab\",\n      \"pmids\": [\"20659469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NOBOX is an essential maternal-derived transcription factor in bovine early embryogenesis; siRNA-mediated knockdown of NOBOX in bovine embryos blocked development to the blastocyst stage, downregulated genes involved in transcriptional regulation, signal transduction, and cell cycle, and reduced pluripotency gene expression (POU5F1/OCT4 and NANOG) and inner cell mass cell number.\",\n      \"method\": \"siRNA knockdown, RT-PCR, immunofluorescence, blastocyst development assay\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined cellular and molecular phenotypes, single lab, bovine model\",\n      \"pmids\": [\"21193554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"miR-196a directly targets the 3' UTR of bovine NOBOX mRNA to repress NOBOX protein expression; a miR-196a binding site was identified by algorithm, validated by luciferase reporter assay (suppressed by miR-196a, rescued by site-directed mutation of MRE), and ectopic miR-196a in bovine embryos reduced NOBOX at both mRNA and protein levels.\",\n      \"method\": \"Luciferase reporter assay, site-directed mutagenesis, ectopic miRNA expression in embryos, Western blot\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal methods including mutagenesis and in-embryo validation, single lab, bovine model\",\n      \"pmids\": [\"21548929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NOBOX directly transactivates the KIT-L (KITLG/stem cell factor) promoter, identifying KIT-L as a novel direct transcriptional target of NOBOX, confirmed by luciferase reporter assay with POI-associated NOBOX mutations showing reduced KIT-L transactivation.\",\n      \"method\": \"Luciferase reporter assay, mutational analysis in patient-derived variants\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assay with multiple disease alleles tested, single lab\",\n      \"pmids\": [\"25514101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A novel NOBOX isoform identified in human fetal ovary (distinct from the canonical transcript) is capable of upregulating the GDF9 promoter in reporter assays, demonstrating that isoform-specific transcriptional regulation of GDF9 by NOBOX occurs during human oogenesis.\",\n      \"method\": \"qRT-PCR, luciferase reporter assay, NOBOX isoform cloning from human fetal ovary\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assay with novel isoform, single lab\",\n      \"pmids\": [\"25790371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A homozygous NOBOX truncating variant (chr7:144098161delC) causes severe loss-of-function: the truncated NOBOX protein fails to transactivate the GDF9 promoter, reduces expression of multiple oocyte-related genes, and loses the ability to induce G2/M cell-cycle arrest; the 1725 bp NOBOX transcript expressed in human fetal ovary was confirmed as the only functional isoform in transcriptional activation assays.\",\n      \"method\": \"Luciferase reporter assay, qRT-PCR, cell cycle analysis, whole exome sequencing, isoform functional comparison\",\n      \"journal\": \"Human reproduction (Oxford, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays characterizing loss-of-function mechanism, single lab\",\n      \"pmids\": [\"27836978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Multiple NOBOX variants associated with POI (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449*, p.D452N) exhibit variable functional defects including impaired transcriptional activity, autophagosomal protein degradation, defective nuclear localization, and protein instability; several variants retain the ability to interact with FOXL2 and form intracellular aggregates.\",\n      \"method\": \"Immunolocalization, Western blot, transcriptional assays, co-localization in HEK293T and CHO cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional assays across multiple alleles, single lab\",\n      \"pmids\": [\"27798098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RSPO2 is a direct transcriptional target of NOBOX: the RSPO2 promoter contains a NOBOX binding element (NBE), and NOBOX activates RSPO2 promoter-driven transcription in reporter assays.\",\n      \"method\": \"Promoter cloning, luciferase reporter assay, NBE identification\",\n      \"journal\": \"Journal of ovarian research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single reporter assay, single lab, no ChIP or binding confirmation\",\n      \"pmids\": [\"28743298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Xenopus, a Nobox-binding element (NBE) in the proximal promoter of the hb4 gene is essential for its transcriptional activation specifically in oocytes, and Nobox expressed in the ovary drives hb4 transcription through this NBE, demonstrated by deletion analysis and luciferase reporter assays in transgenic frogs.\",\n      \"method\": \"Transgenic reporter analysis, promoter deletion constructs, luciferase reporter assay\",\n      \"journal\": \"Zygote (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic validation plus reporter assays, single lab, Xenopus model consistent with mammalian NOBOX function\",\n      \"pmids\": [\"31250783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss of nobox in zebrafish (CRISPR/Cas9 knockout) prevents follicles from developing beyond the primary growth (perinucleolar) stage, resulting in all-male phenotype; follicle assembly from cystic oocytes occurs but follicles fail to progress to functional ovaries, indicating Nobox is required for follicle development after initial assembly.\",\n      \"method\": \"CRISPR/Cas9 knockout, histological analysis, zebrafish model\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined loss-of-function phenotype with specific developmental stage arrest, single lab, zebrafish ortholog\",\n      \"pmids\": [\"35157068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In zebrafish nobox-/-;dmrt1-/- double mutants, follicles form and progress to previtellogenic (PV) stage but fail to enter vitellogenic growth due to a deficiency in estrogen signaling, evidenced by reduced ovarian aromatase (cyp19a1a) expression, decreased serum estradiol, regressed female secondary sex characteristics, and rescue of vitellogenic growth by exogenous E2 treatment; Nobox may regulate cyp19a1a via control of Gdf9 and/or Bmp15.\",\n      \"method\": \"Genetic epistasis (nobox-/-;dmrt1-/- double mutant), qRT-PCR, serum hormone measurement, E2 rescue experiment, zebrafish model\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with defined rescue experiment placing Nobox upstream of estrogen signaling in folliculogenesis, single lab\",\n      \"pmids\": [\"37990081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mouse NOBOX is sumoylated by SUMO2/3 at a non-consensus site (K97); loss of NOBOX sumoylation at K97 (K97R mutation) increases transcriptional activity on the Gdf9 promoter but has no effect on the Pou5f1 promoter; K97R/K125R double mutants show altered higher molecular weight SUMO modifications, suggesting cooperation between these lysines in regulating NOBOX transcriptional output.\",\n      \"method\": \"Site-directed mutagenesis, sumoylation assay, luciferase reporter assay, Western blot\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sumoylation site identified by mutagenesis with functional consequences on promoter activity, single lab\",\n      \"pmids\": [\"36607631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A distal NOBOX binding element (NBE) at -1.8 kb upstream of the TSS in the buffalo GDF9 promoter enhances GDF9 promoter activity in buffalo oocytes; site-directed mutation of the core NBE nucleotides abolished this enhancement, confirming the NBE is required for NOBOX-mediated transcriptional activation of GDF9.\",\n      \"method\": \"Promoter deletion constructs, luciferase reporter assay, GFP reporter, site-directed mutagenesis, oocyte transfection\",\n      \"journal\": \"Animal reproduction science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of binding element in native oocyte context with two orthogonal reporters, single lab\",\n      \"pmids\": [\"23078866\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOBOX is an oocyte-specific homeodomain transcription factor that binds NOBOX binding elements (NBEs; core sequences TAATTG, TAGTTG, TAATTA) in target gene promoters to directly activate transcription of oocyte-specific genes including Gdf9, Pou5f1/Oct4, Pad6, KIT-L, and Rspo2; its transcriptional activity is regulated post-translationally by SUMO2/3 modification at K97, and disease-causing mutations disrupt DNA binding, nuclear localization, protein stability, or transactivation capacity; loss of NOBOX in mice and zebrafish blocks the transition from primordial to growing follicles and impairs downstream estrogen signaling, while NOBOX also functions as an essential maternal transcription factor during early embryogenesis in bovines.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NOBOX is an oocyte-specific homeodomain transcription factor that drives the primordial-to-growing follicle transition by directly activating an oocyte gene expression program [#0, #2]. It binds defined NOBOX binding elements (NBEs; core sequences TAATTG, TAGTTG, TAATTA) in target promoters and transactivates a set of oocyte-specific and pluripotency genes including Gdf9, Pou5f1/Oct4, Pad6, and KIT-L/KITLG [#0, #5, #8]. Genome-wide loss-of-function in mice establishes NOBOX as both an activator of oocyte-specific genes (Pou5f1, Sall4, Astl, Rspo2 among others) and a suppressor of the male-determining gene Dmrt1 [#2]; at the cellular level Nobox loss disrupts germ cell cyst breakdown and somatic cell invasion, producing syncytial rather than primordial follicles [#4]. In zebrafish, nobox is required for follicles to progress beyond the primary growth stage, and genetic epistasis places Nobox upstream of estrogen signaling, acting through aromatase (cyp19a1a) and Gdf9/Bmp15 to license vitellogenic growth [#14, #15]. Beyond its ovarian role, NOBOX functions as an essential maternal transcription factor in bovine early embryogenesis, where its knockdown blocks blastocyst development and reduces pluripotency gene expression [#6]. NOBOX transcriptional output is tuned post-translationally by SUMO2/3 modification at K97, loss of which selectively elevates activity on the Gdf9 promoter [#16]. Human NOBOX mutations cause primary ovarian insufficiency: missense and truncating variants impair DNA binding, transactivation, nuclear localization, and protein stability, with a homeodomain mutation (p.Arg355His) acting dominant-negatively on wild-type DNA binding [#1, #3, #10, #11].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established NOBOX as a sequence-specific DNA-binding transcription factor with defined recognition elements and direct target genes, converting it from a candidate oocyte factor into a defined transcriptional activator.\",\n      \"evidence\": \"CAST selection, EMSA, ChIP, and luciferase reporters defining NBEs and direct activation of Pou5f1 and Gdf9\",\n      \"pmids\": [\"16997917\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full target repertoire not defined\", \"Co-activators/co-repressors at NBEs not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed that a disease homeodomain mutation abolishes NBE binding and acts dominant-negatively, linking NOBOX DNA-binding function directly to human ovarian disease mechanism.\",\n      \"evidence\": \"EMSA with the p.Arg355His mutant in human POI patients\",\n      \"pmids\": [\"17701902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dominant-negative mechanism not tested in vivo\", \"Effect on transcription of endogenous targets not shown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the genome-wide consequences of Nobox loss, establishing it as an activator of oocyte genes and a suppressor of the male-determining gene Dmrt1.\",\n      \"evidence\": \"Affymetrix microarray and protein-binding microarray in Nobox knockout mouse ovary\",\n      \"pmids\": [\"17494914\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect targets not fully distinguished\", \"Mechanism of Dmrt1 suppression unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the cellular phenotype of Nobox loss as failed cyst breakdown and somatic invasion, connecting transcriptional activity to follicle architecture.\",\n      \"evidence\": \"Electron microscopy of Nobox knockout mouse ovaries\",\n      \"pmids\": [\"21369782\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Target genes mediating cyst breakdown not identified\", \"Adherens junction link to NOBOX targets unestablished\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Expanded the direct target set to Pad6 and established NOBOX as a maternal transcription factor required for early embryogenesis beyond the ovary.\",\n      \"evidence\": \"EMSA and reporter assays for Pad6; siRNA knockdown with blastocyst assays in bovine embryos\",\n      \"pmids\": [\"20659469\", \"21193554\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Maternal vs zygotic contribution not separated\", \"Embryonic targets only partially defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified post-transcriptional control of NOBOX by miR-196a and refined haploinsufficiency as the mechanism for POI-associated alleles.\",\n      \"evidence\": \"Luciferase 3'UTR reporter with MRE mutagenesis and in-embryo miRNA expression; transactivation assays of five POI missense/nonsense alleles on GDF9\",\n      \"pmids\": [\"21548929\", \"21837770\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"miR-196a regulation shown in bovine only\", \"Allele-specific quantitative contribution to haploinsufficiency unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped a functional distal NBE in the GDF9 promoter, confirming NBE-dependent transactivation in a native oocyte context.\",\n      \"evidence\": \"Promoter deletion and NBE mutagenesis with dual reporters in buffalo oocytes\",\n      \"pmids\": [\"23078866\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous occupancy not confirmed by ChIP\", \"Proximal vs distal NBE cooperation not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Added KIT-L/KITLG to the direct NOBOX target set and tied POI mutations to reduced KIT-L transactivation, connecting NOBOX to somatic-germ cell signaling ligands.\",\n      \"evidence\": \"Luciferase reporter assays with patient-derived NOBOX variants\",\n      \"pmids\": [\"25514101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding to KIT-L promoter not confirmed by ChIP/EMSA\", \"In vivo relevance not shown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated isoform-specific transcriptional regulation of GDF9 during human oogenesis, refining which NOBOX transcript carries activity.\",\n      \"evidence\": \"Isoform cloning from human fetal ovary with GDF9 reporter assays\",\n      \"pmids\": [\"25790371\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative abundance/role of isoforms in vivo unclear\", \"Structural basis of isoform activity not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Characterized the loss-of-function spectrum of human NOBOX variants, revealing multiple convergent defects (transactivation, nuclear localization, stability, autophagic degradation, cell-cycle arrest) and confirming the single functional fetal-ovary isoform.\",\n      \"evidence\": \"Reporter, qRT-PCR, cell-cycle, immunolocalization, Western blot across multiple POI alleles and a homozygous truncating variant\",\n      \"pmids\": [\"27836978\", \"27798098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FOXL2 interaction functional consequence not resolved\", \"Aggregate formation mechanism unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Proposed RSPO2 as an additional direct NOBOX target via an NBE-containing promoter.\",\n      \"evidence\": \"Promoter cloning and luciferase reporter assay\",\n      \"pmids\": [\"28743298\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single reporter assay with no ChIP or binding confirmation\", \"In vivo dependence not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided in vivo transgenic evidence that an NBE drives oocyte-specific transcription, generalizing NOBOX-NBE regulation to a vertebrate ovarian gene.\",\n      \"evidence\": \"Transgenic reporter and promoter deletion analysis of hb4 in Xenopus\",\n      \"pmids\": [\"31250783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous hb4 regulation not assayed in knockouts\", \"Conservation of mechanism in mammals not directly shown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined the developmental requirement for nobox after follicle assembly, showing arrest at primary growth stage and an all-male phenotype.\",\n      \"evidence\": \"CRISPR/Cas9 knockout and histology in zebrafish\",\n      \"pmids\": [\"35157068\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular targets mediating arrest not identified\", \"Sex-reversal mechanism not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placed Nobox upstream of estrogen signaling in folliculogenesis via genetic epistasis, showing failure of vitellogenic growth rescuable by exogenous E2.\",\n      \"evidence\": \"nobox-/-;dmrt1-/- double mutants with qRT-PCR, serum estradiol, and E2 rescue in zebrafish\",\n      \"pmids\": [\"37990081\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct regulation of cyp19a1a vs via Gdf9/Bmp15 not distinguished\", \"Mammalian conservation of this axis untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified SUMO2/3 modification at K97 as a post-translational regulator that selectively tunes NOBOX transcriptional output on the Gdf9 promoter.\",\n      \"evidence\": \"Site-directed mutagenesis (K97R, K125R), sumoylation assay, and luciferase reporters\",\n      \"pmids\": [\"36607631\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SUMO E3 ligase and timing in vivo unknown\", \"Promoter selectivity mechanism for Gdf9 vs Pou5f1 unexplained\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NOBOX integrates co-factor binding (e.g. FOXL2), SUMO modification, and isoform selection to achieve promoter-specific target selection in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of NOBOX-NBE or NOBOX-cofactor complexes\", \"Direct in vivo occupancy across the full target set not mapped\", \"Mechanism coordinating Dmrt1 suppression with oocyte gene activation unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 5, 8, 16]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5, 8]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [4, 14, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FOXL2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}